Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle - Test2 - elhamkhani - TriplyDB

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

http://www.wikidata.org/entity/Q28199082

about

sameAs

Argininosuccinate synthase: at the center of arginine metabolism Restructuring of the dinucleotide-binding fold in an NADP(H) sensor protein Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase Leishmania donovani argininosuccinate synthase is an active enzyme associated with parasite pathogenesis Genetic Manipulation of Leishmania donovani to Explore the Involvement of Argininosuccinate Synthase in Oxidative Stress Management Argininosuccinate synthetase is a functional target for a snake venom anti-hypertensive peptide: role in arginine and nitric oxide production.A transgenic approach to study argininosuccinate synthetase gene expression.Mass spectrometry-based analysis of murine bronchoalveolar lavage fluid following respiratory exposure to 4,4'-methylene diphenyl diisocyanate aerosol Molecular profiling of platinum resistant ovarian cancer.Arthritis suppression by NADPH activation operates through an interferon-beta pathway Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53 The combination of ADI-PEG20 and TRAIL effectively increases cell death in melanoma cell lines.Differential expression of liver proteins between obesity-prone and obesity-resistant rats in response to a high-fat diet.Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells.Liver proteomics in progressive alcoholic steatosis.Coagulase-negative Staphylococci favor conversion of arginine into ornithine despite a widespread genetic potential for nitric oxide synthase activity.Expression profile and down-regulation of argininosuccinate synthetase in hepatocellular carcinoma in a transgenic mouse model Cytokines Modulate the "Immune-Metabolism" Interactions during Behçet Disease: Effect on Arginine Metabolism.Reciprocal changes of renal neuronal nitric oxide synthase-α and -β associated with renal progression in a neonatal 5/6 nephrectomized rat model.Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy.Identification and characterization of genes involved in leishmania pathogenesis: the potential for drug target selection.Spatial mapping of protein abundances in the mouse brain by voxelation integrated with high-throughput liquid chromatography-mass spectrometry Partial deletion of argininosuccinate synthase protects from pyrazole plus lipopolysaccharide-induced liver injury by decreasing nitrosative stress.Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy.Angiotensin-converting enzyme inhibitors of Bothrops jararaca snake venom affect the structure of mice seminiferous epithelium Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase.Improved Survival and Initiation of Differentiation of Human Induced Pluripotent Stem Cells to Hepatocyte-Like Cells upon Culture in William's E Medium followed by Hepatocyte Differentiation Inducer Treatment.Hepatocyte selection medium eliminating induced pluripotent stem cells among primary human hepatocytes.Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma Therapeutic use of citrulline in cardiovascular disease.Does Citrulline Have Protective Effects on Liver Injury in Septic Rats?Differential expression of argininosuccinate synthetase in serous and non-serous ovarian carcinomas.ASS and SULT2A1 are Novel and Sensitive Biomarkers of Acute Hepatic Injury-A Comparative Study in Animal Models.Increased mitochondrial arginine metabolism supports bioenergetics in asthma.Role of TNF-alpha in vascular dysfunction.Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis.Blood pressure follows the kidney: Perinatal influences on hereditary hypertension Arginine deprivation as a targeted therapy for cancer.Pharmacodynamic modeling of acute and chronic effects of methylprednisolone on hepatic urea cycle genes in rats.Ethanol plus the Jo2 Fas agonistic antibody-induced liver injury is attenuated in mice with partial ablation of argininosuccinate synthase.

P2860

Q24620561-39177645-9900-4A77-B535-C271A4866AC6 Q27644747-F8D08628-CF0C-4550-B00C-2C1F5C18FB7C Q28288793-956C0DC3-1F15-4194-BC30-8A32C300AEDC Q28484484-1F7C8760-0380-438C-B610-6D18FF0B4983 Q28550531-B1E5DBB9-4D93-481D-B28B-D737D29772A0 Q29144136-7C8C2614-216C-4A66-9B6C-8390FE7E5B5F Q31162072-A03FB430-1F41-4BC8-A243-AD6309CB4E70 Q32944349-28A6ADA4-D839-409C-9117-DD72912B1B3B Q33227163-FC1F1706-3EC7-4865-81BA-14EF55AC20F4 Q33284147-C384CE09-38E7-4DB4-89D8-9985D1FA6466 Q33708112-B271A1D4-72E3-427D-97AE-256F95AF9BFF Q33815463-8E785843-BE07-4ECD-9FF5-5AC661228616 Q33887597-34FFC7E2-F625-4B5A-9219-0114F424E5C2 Q34497105-C9F5F32C-ECB0-4FD3-A7B2-1605B7BED737 Q34497163-3FD117D5-FF1A-4318-9959-297A695400DB Q34595505-4E1A0E8A-7195-4652-9E7A-015C5E1FC58E Q35021230-839BBA63-4D7D-406A-B821-10C4DD9C7A01 Q35066832-BCB71C93-AE08-44E8-B692-1F5FA3A8F5C8 Q35167343-B1DE0B99-A378-43A3-9060-BE5DFC096580 Q35233239-127938E6-B84A-41B7-B6EE-59C7FCE99937 Q35430594-65E91921-A455-4097-8239-A5E71BAB0E07 Q35642489-E35258AC-65C7-4737-AF07-C1FDF0288FA4 Q35780911-340D80F8-95C8-4C28-830E-55D2122D55EE Q35803555-175E7981-0617-4092-9960-6CB10CE6B681 Q35913991-92ED7F32-027C-4CC9-AF80-119E770DF6B8 Q35927116-D8620B4C-2D3B-4FBB-BBC0-F09B0A5938EE Q35988348-037BDC88-5EEB-4AC9-85F7-829E56DCD3EB Q36065349-FEE92812-17B4-48FE-936F-9469781FCE0B Q36277197-AF4B7D5E-A97B-44E1-8918-5074D33E82FB Q36703841-613AA990-8B30-4508-BF00-A24F33B4C166 Q36860986-63D1ECAA-78AD-44C8-B4CB-C458AD2B5E49 Q36873800-AE235097-BF41-4408-87C3-1BCACDB73B26 Q36880051-ED56F3B7-4C4D-4002-898D-1F8B6F5A66DA Q37042318-57FEB3C2-4996-44D7-9D22-6617A122815D Q37050343-2D9506B8-2182-4393-87FA-99C5CA519F71 Q37068792-B2342097-C032-4069-841B-985C86AE9D50 Q37081774-ED863609-98D4-4306-A9AC-4D6EBDE6ED0B Q37160927-1E462059-41F0-4BA6-8564-801DFE572753 Q37321880-A04E7961-008B-48E1-AEA9-7EE062CE7916 Q37647000-72A56EBD-AC39-46C7-A8DE-9D54826DAC55

P2860

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

http://www.wikidata.org/entity/Q28199082

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

@ast

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

@en

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

@nl

type

label

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

@ast

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

@en

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

@nl

prefLabel

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

@ast

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

@en

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

@nl

P1433

Q28199082-FE2D1CB1-B8FD-42AB-898E-47D613D43170

P1476

Q28199082-7157F6C7-A12A-4928-AA36-5E1EBE17ACDF

P2093

Q28199082-212BC11E-1788-475D-B06E-B26A1F00C163

Q28199082-5352D744-7964-45D1-B809-58A91EF5E372

Q28199082-921E8557-AB71-4775-84F4-21160B350CB0

Q28199082-C134ED62-7B39-4387-A8A2-FD66FC93BEF0

Q28199082-F8AB7159-CD7D-4359-B6E2-D5E767C38FBE

P2860

Q28199082-015871C0-8584-43A7-831E-A57FB312ABB1

Q28199082-0AFE8E39-DF8F-4CD5-BDEF-1C9F50F4B4C3

Q28199082-0BD983F5-C537-46C7-AEA2-16984B158781

Q28199082-0C78D8CB-1F45-4A15-B34F-9FBD1628A4D4

Q28199082-0CB92FAB-6149-4761-8D8C-8947CB7BB3EE

Q28199082-0DEF6BB8-79A4-4235-8310-8C650D81DCFC

Q28199082-102B5931-BAB3-4C1D-9687-2D509F93183B

Q28199082-107A9807-5D39-43B9-97DB-80286BE272B0

Q28199082-119743B6-2F60-4DE2-A0C7-7D127EEA4035

Q28199082-22768EA6-CB58-40C4-80D2-B0BA1DA55C12

P304

Q28199082-40A8B6F3-D341-4B6B-A61D-D4CFF02E5D5A

P31

Q28199082-09B269F4-E55F-4554-9EB3-3A0DB716133F

P3181

Q28199082-599A2200-D3CE-4C06-B948-C8E12A18D273

P356

Q28199082-C877D53D-9723-46DF-BE66-3C5C48F6BFB5

P407

Q28199082-CECEB9F3-B4D0-43A7-A1EA-1BAAE10EAD2D

P433

Q28199082-5E729511-6810-4153-B162-9E5DEA41D0B0

P478

Q28199082-E18BA954-AFFD-4884-B64E-A2FD05E9E68A

P577

Q28199082-22201607-F7DB-4282-ABD8-66C60A7B9ED4

P5875

Q28199082-7FE74972-8917-4C41-B8A6-7F8937E32395

P698

Q28199082-CE787272-CFE9-4A33-991E-5668E8CEBFDF

P3181

P356

J.1432-1033.2003.03559.X

P1433

P1476

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

@en

P2093

Alain Fairand

http://www.w3.org/2001/XMLSchema#string

Alain Lavoinne

http://www.w3.org/2001/XMLSchema#string

Annie Husson

http://www.w3.org/2001/XMLSchema#string

Carole Brasse-Lagnel

http://www.w3.org/2001/XMLSchema#string

Sylvie Renouf

http://www.w3.org/2001/XMLSchema#string

P2860

ATF4 is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene

Cellular and subcellular localization of enzymes of arginine metabolism in rat kidney

Nitric oxide synthases in mammals

Arginine metabolism: nitric oxide and beyond

Molecular structure of the human argininosuccinate synthetase gene: occurrence of alternative mRNA splicing

Substrate induced conformational changes in argininosuccinate synthetase

Crystal structure of argininosuccinate synthetase from Thermus thermophilus HB8. Structural basis for the catalytic action

Regulation of enzymes of the urea cycle and arginine metabolism

Nitric oxide synthases: structure, function and inhibition

The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia

P304

1887-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

601563

http://www.w3.org/2001/XMLSchema#string

P356

10.1046/J.1432-1033.2003.03559.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

270

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7455458

http://www.w3.org/2001/XMLSchema#string

P698

12709047

http://www.w3.org/2001/XMLSchema#string